Inbiomotion, the @irbbarcelona.org spin-off founded by #ICREAResearcher Roger Gomis, will bring the MAF Test® to patients in South Korea! 🏥
This test for identifying high-risk early-stage breast cancer patients is increasing its international projection. Congratulations!👏
ICREA Community
🧪 The MAF Test®, developed by #IRBBarcelona & @icreacommunity.bsky.social spin-off Inbiomotion, is now available in South Korea.
This is the 1st #IRBBarcelona research-based product to reach patients there. The test could benefit ~34,000 new #BreastCancer patients each year.
👉 shorturl.at/qVsfh
